FR2434622A1 - Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer - Google Patents

Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer

Info

Publication number
FR2434622A1
FR2434622A1 FR7921975A FR7921975A FR2434622A1 FR 2434622 A1 FR2434622 A1 FR 2434622A1 FR 7921975 A FR7921975 A FR 7921975A FR 7921975 A FR7921975 A FR 7921975A FR 2434622 A1 FR2434622 A1 FR 2434622A1
Authority
FR
France
Prior art keywords
cancer patients
feeding
amino acid
acid solutions
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7921975A
Other languages
English (en)
French (fr)
Other versions
FR2434622B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2434622A1 publication Critical patent/FR2434622A1/fr
Application granted granted Critical
Publication of FR2434622B1 publication Critical patent/FR2434622B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7921975A 1978-09-04 1979-09-03 Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer Granted FR2434622A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
FR2434622A1 true FR2434622A1 (fr) 1980-03-28
FR2434622B1 FR2434622B1 (enExample) 1983-04-15

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7921975A Granted FR2434622A1 (fr) 1978-09-04 1979-09-03 Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer

Country Status (10)

Country Link
JP (1) JPS5535049A (enExample)
AU (1) AU526207B2 (enExample)
CA (1) CA1134275A (enExample)
CH (1) CH642541A5 (enExample)
DE (1) DE2935709C2 (enExample)
FR (1) FR2434622A1 (enExample)
GB (1) GB2029220B (enExample)
IT (1) IT1194844B (enExample)
NL (1) NL190266C (enExample)
SE (1) SE448679B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591893A1 (fr) * 1985-12-19 1987-06-26 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58500526A (ja) * 1981-04-17 1983-04-07 アメリカン　ホスピタル　サプライ　コ−ポレ−シヨン 非経口栄養供給のための改良溶液
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
ATE183923T1 (de) * 1991-10-07 1999-09-15 Otsuka Pharma Co Ltd Enterale zubereitungen zur krebstherapie
DE4228897A1 (de) * 1992-08-29 1994-03-03 Wella Ag Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
JP2930723B2 (ja) * 1992-11-19 1999-08-03 アンティキャンサー インコーポレーテド 抗メチオニン化学療法における抗腫瘍薬としてのメチオニナーゼの使用
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
RU2125874C1 (ru) * 1994-07-04 1999-02-10 Казанский государственный университет им.В.И.Ульянова-Ленина Композиция аминокислот с микроэлементами, обладающая противоопухолевой и антигипоксической активностью
EP0921794A1 (en) * 1996-07-30 1999-06-16 Novartis Nutrition AG Amino acid composition and use thereof in treating tumor growth and metastasis
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
RU2144821C1 (ru) * 1999-02-16 2000-01-27 Товарищество с ограниченной ответственностью Фирма "ГЛЕС" Противоопухолевое средство
ATE323479T1 (de) * 2000-06-16 2006-05-15 Matthias Dr Med Rath Zusammensetzung für die verhinderung der glattmuskelkrankheiten, die ascorbat, arginin und magnesium enthält
ES2261136T3 (es) * 2000-10-09 2006-11-16 Matthias Dr. Med. Rath Composicion terapeutica de ascorbato con lisina y arginina para prevencion y tratamiento del cancer.
CH694549A5 (de) 2001-01-16 2005-03-31 Dr Matthias Rath Verwendung einer synergistischen Zusammensetzung, die Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeration.
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
WO2003030890A1 (fr) * 2001-10-05 2003-04-17 Tetsuro Asao Activateurs du systeme immunitaire
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
WO2005092097A1 (en) * 2004-03-19 2005-10-06 Pro-Pharmaceuticals, Inc. Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
PT1909600E (pt) 2005-07-29 2012-07-24 Tima Foundation Composição para moderar o metabolismo do álcool e para reduzir o risco de doenças induzidas pelo álcool
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016955A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Alcohol metabolism moderating composition
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
EP2156188B1 (en) 2007-03-28 2021-05-05 University of Southern California Induction of differential stress resistance and uses thereof
ES2800327T3 (es) 2008-04-24 2020-12-29 Univ Of Southern California Usc Stevens Composiciones dietéticas y métodos de protección contra la quimioterapia o radioterapia
WO2012111790A1 (ja) * 2011-02-17 2012-08-23 味の素株式会社 化学療法剤の抗腫瘍活性増強剤
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
IT201900002109A1 (it) 2019-02-13 2020-08-13 Professional Dietetics Spa Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro
IT202000000442A1 (it) 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2008137A1 (enExample) * 1968-05-09 1970-01-16 Astra Ab
DE2013026A1 (en) * 1970-03-19 1971-10-07 Wagner, Karl Heinz, Dr med habil Prof, 63O0Giessen Amino acid compsn against liver diseases
FR2316933A1 (fr) * 1975-07-07 1977-02-04 Fresenius Chem Pharm Ind Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU423304A3 (enExample) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2531204C2 (de) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-Aminosäuregemische für die parenterale oder orale Ernährung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2008137A1 (enExample) * 1968-05-09 1970-01-16 Astra Ab
DE2013026A1 (en) * 1970-03-19 1971-10-07 Wagner, Karl Heinz, Dr med habil Prof, 63O0Giessen Amino acid compsn against liver diseases
FR2316933A1 (fr) * 1975-07-07 1977-02-04 Fresenius Chem Pharm Ind Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1959 *
CA1970 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591893A1 (fr) * 1985-12-19 1987-06-26 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
WO1987003810A1 (fr) * 1985-12-19 1987-07-02 Centre National De La Recherche Scientifique (Cnrs Compositions nutritionnelles carencees en methionine et supplementee en homocysteine
EP0232652A1 (fr) * 1985-12-19 1987-08-19 Centre National De La Recherche Scientifique (Cnrs) Compositions nutritionnelles carencées en méthionine et supplémentées en homocystéine

Also Published As

Publication number Publication date
DE2935709A1 (de) 1980-03-13
AU526207B2 (en) 1982-12-23
FR2434622B1 (enExample) 1983-04-15
NL7906620A (nl) 1980-03-06
CH642541A5 (de) 1984-04-30
IT7905216A0 (it) 1979-09-03
IT1194844B (it) 1988-09-28
JPS5535049A (en) 1980-03-11
SE448679B (sv) 1987-03-16
AU5036879A (en) 1980-03-13
NL190266B (nl) 1993-08-02
DE2935709C2 (de) 1986-02-06
NL190266C (nl) 1994-01-03
SE7907316L (sv) 1980-03-05
GB2029220A (en) 1980-03-19
CA1134275A (en) 1982-10-26
JPS6154007B2 (enExample) 1986-11-20
GB2029220B (en) 1983-03-30

Similar Documents

Publication Publication Date Title
FR2434622A1 (fr) Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer
ATE213389T1 (de) Antemortem futterzusatz für lebendes vieh
BE1002296A5 (fr) Derives peptidiques.
DK0751769T3 (da) Medicinsk behandling under anvendelse af skjoldbruskhormoner
EP0651652A4 (en) SENSITIVE TEETH TREATMENT.
GB1511302A (en) Pharmaceutical compositions comprising amino acid analogues
SE9403526D0 (sv) New Peptides
IE852596L (en) Peptides active on the cns
BR9104997A (pt) Complexos ligados em ponte a hidrogenio,processo para sua preparacao farmaceutica
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
ES2072244T1 (es) Compuestos y productos de reaccion de amadori, procedimiento para su fabricacion y uso de los mismos.
IT1250636B (it) Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
Nettelbladt et al. Amino-acid content of serum in rheumatoid arthritis
KR910009267A (ko) 우울증의 치료방법
JO1195B1 (en) Pharmaceutical preparations for the treatment of cyanosis and ocular hypertension
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
EP0740935A4 (en) ANALGETIC ACTIVITY AMPLIFIER
JPS5668374A (en) Food composition for hepatic insufficiency
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
CA2099529A1 (en) Antemortem nutrient supplement for livestock
KR890000399A (ko) (e)-2-(p-플루오로펜에틸)-3-플루오로알릴아민
DE3867039D1 (de) Vincristin enthaltendes produkt.
FI943733A0 (fi) Amadori-reaktioyhdisteet ja -tuotteet, menetelmä niiden valmistamiseksi sekä niiden käyttö
ATE8966T1 (de) Analgetische potenzierung.
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta